| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 8888888 |
Internal/system code - not a standard HCPCS code |
41,528 |
10,075 |
$8.85M |
| 80053 |
Comprehensive metabolic panel |
12,021 |
9,543 |
$346K |
| 36415 |
Collection of venous blood by venipuncture |
4,472 |
3,493 |
$305K |
| 83605 |
|
3,776 |
2,921 |
$284K |
| 84484 |
|
3,543 |
2,497 |
$280K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,466 |
5,798 |
$234K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,145 |
8,616 |
$200K |
| 80306 |
|
2,271 |
1,901 |
$131K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,259 |
1,133 |
$119K |
| 86850 |
|
904 |
814 |
$85K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,664 |
1,346 |
$62K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,338 |
2,064 |
$47K |
| 0225U |
|
494 |
448 |
$38K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,595 |
1,395 |
$36K |
| 71045 |
Radiologic examination, chest; single view |
3,291 |
2,819 |
$34K |
| 87400 |
|
696 |
614 |
$34K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
596 |
558 |
$34K |
| 86901 |
|
1,094 |
983 |
$33K |
| 71046 |
Radiologic examination, chest; 2 views |
1,283 |
1,138 |
$32K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,685 |
4,001 |
$31K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
738 |
699 |
$31K |
| 81025 |
|
2,155 |
1,858 |
$28K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,248 |
1,917 |
$27K |
| 81001 |
|
8,072 |
6,586 |
$26K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,484 |
479 |
$24K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,779 |
1,552 |
$24K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
168 |
159 |
$19K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,694 |
2,098 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
472 |
436 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,845 |
10,748 |
$15K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,341 |
2,804 |
$14K |
| 87430 |
|
369 |
350 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,990 |
1,666 |
$12K |
| 82962 |
|
1,794 |
985 |
$11K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
633 |
572 |
$10K |
| 87186 |
|
888 |
795 |
$10K |
| 85610 |
|
2,095 |
1,725 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,809 |
1,584 |
$9K |
| 76830 |
Ultrasound, transvaginal |
180 |
157 |
$8K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,931 |
3,848 |
$8K |
| 31720 |
|
78 |
48 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,786 |
1,496 |
$6K |
| 87807 |
|
249 |
232 |
$6K |
| 83690 |
|
4,203 |
3,423 |
$6K |
| 84703 |
|
1,429 |
1,244 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
33 |
30 |
$5K |
| 73610 |
|
59 |
55 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
506 |
479 |
$5K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
141 |
132 |
$4K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
55 |
50 |
$4K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
230 |
176 |
$4K |
| 73630 |
|
70 |
63 |
$4K |
| 86900 |
|
922 |
830 |
$4K |
| 83880 |
|
503 |
431 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
129 |
119 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,582 |
1,055 |
$3K |
| 59025 |
Fetal non-stress test |
60 |
40 |
$3K |
| 84702 |
|
296 |
206 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,601 |
3,714 |
$2K |
| 93971 |
|
26 |
25 |
$2K |
| 85379 |
|
797 |
705 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
301 |
107 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,704 |
3,946 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
121 |
102 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
160 |
150 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
469 |
418 |
$2K |
| 74018 |
|
44 |
38 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,921 |
2,262 |
$1K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
44 |
39 |
$1K |
| 82805 |
|
53 |
41 |
$1K |
| G0378 |
Hospital observation service, per hour |
869 |
755 |
$1K |
| 80320 |
|
1,265 |
1,042 |
$1K |
| 73130 |
|
17 |
14 |
$842.27 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
639 |
450 |
$781.05 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
30 |
25 |
$752.11 |
| 87081 |
|
160 |
147 |
$733.82 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
125 |
106 |
$685.81 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
680 |
202 |
$654.63 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
293 |
233 |
$644.17 |
| 82550 |
|
25 |
24 |
$603.64 |
| 97161 |
|
277 |
229 |
$545.71 |
| 87999 |
|
13 |
12 |
$515.64 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
489 |
416 |
$359.68 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
131 |
120 |
$337.96 |
| 72100 |
|
12 |
12 |
$323.75 |
| 80299 |
|
1,678 |
1,003 |
$224.69 |
| 80061 |
Lipid panel |
60 |
53 |
$186.65 |
| 84439 |
|
47 |
43 |
$162.58 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
400 |
343 |
$138.88 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,465 |
1,257 |
$137.14 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
224 |
200 |
$102.92 |
| 87088 |
|
516 |
464 |
$96.24 |
| 86140 |
|
91 |
62 |
$81.78 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
814 |
667 |
$70.27 |
| 82950 |
|
178 |
168 |
$35.97 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
69 |
65 |
$26.47 |
| 87040 |
|
690 |
355 |
$19.57 |
| 83735 |
|
379 |
287 |
$19.46 |
| 85027 |
|
25 |
24 |
$5.71 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
654 |
577 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
455 |
380 |
$0.00 |
| 96376 |
|
1,069 |
886 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
224 |
184 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
1,017 |
886 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,064 |
776 |
$0.00 |
| 80329 |
|
205 |
175 |
$0.00 |
| 94761 |
|
1,380 |
1,130 |
$0.00 |
| J1741 |
Injection, ibuprofen, 100 mg |
249 |
218 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
80 |
68 |
$0.00 |
| 80050 |
General health panel |
14 |
12 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
80 |
63 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
19 |
15 |
$0.00 |
| 85652 |
|
31 |
24 |
$0.00 |
| 82150 |
|
14 |
14 |
$0.00 |
| 70496 |
|
14 |
12 |
$0.00 |
| 85730 |
|
41 |
37 |
$0.00 |
| 70498 |
|
14 |
12 |
$0.00 |
| 87210 |
|
15 |
13 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
606 |
527 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
18 |
15 |
$0.00 |
| 84145 |
|
13 |
13 |
$0.00 |
| 76937 |
|
15 |
13 |
$0.00 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
61 |
54 |
$0.00 |
| 87631 |
|
17 |
14 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
17 |
13 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
20 |
13 |
$0.00 |